Photo of Susan B. Olson, Ph.D.

Susan B. Olson Ph.D.

    • Professor of Molecular and Medical Genetics School of Medicine
    • Molecular and Medical Genetics Graduate Program School of Medicine
    • Program in Molecular and Cellular Biosciences School of Medicine

Dr. Olson`s special areas of interest include the role of chromosomal changes in fetal development and survival, cancer and genetic disease and the cellular and molecular basis of Fanconi Anemia. She currently is the Director of the Clinical Cytogenetic Laboratory at OHSU. Dr. Olson received her doctorate on 1984 from OHSU, which is also where she completed her fellowship in Medical Genetics-C.C.D.

  • Fellowship:

    • Medical Genetics-C.C.D., Oregon Health Sciences University, Portland

Memberships and associations

  • Clinical cytogenetics, 1987; Ph.D., Medical Genetics, 1987

Publications

  • "Aneuploidy as a mechanism for stress-induced liver adaptation" Journal of Clinical Investigation September 4 2012
  • "DNA interstrand crosslink repair in mammalian cells" Journal of Cellular Physiology September 2009
  • "Trisomy 8 as the sole cytogenetic abnormality in a case of extraskeletal mesenchymal chondrosarcoma" Cancer Genetics and Cytogenetics June 2005
  • "Chromosomes 1 and 12 abnormalities in pediatric germ cell tumors by interphase fluorescence in situ hybridization" Cancer Genetics and Cytogenetics March 2001
  • "Pregnancy loss in a small chorionic villus sampling series" American Journal of Obstetrics and Gynecology  1989
  • "Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks" Molecular and Cellular Biology January 2006
  • "Cell fusion is the principal source of bone-marrow-derived hepatocytes" Nature April 24 2003
  • "Erratum to" Chromosome Research December 6 2014
  • "Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia" Blood July 1 2003
  • "DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links" Molecular and Cellular Biology  2000
  • "Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate" Leukemia March 1 2003
  • "Selective pressure as an essential force in molecular evolution of myeloid leukemic clones" Leukemia  1999
  • "MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting" Annals of Hematology November 22 2015
  • "Cisplatin and the sensitive cell" Nature Medicine May 1 2003
  • "Aberrations of MYC are a common event in B-cell prolymphocytic leukemia" American Journal of Clinical Pathology September 1 2014
  • "Fanconi anemia group A and C double-mutant mice" Experimental Hematology  2002
  • "Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells" Annals of Surgical Oncology February 2010
  • "Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice" Stem Cell Research September 2013
  • "Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining" Human Molecular Genetics October 2005
  • "Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation" Somatic Cell and Molecular Genetics  1998
  • "Cytogenetic evidence for involvement of B lymphocytes in acquired idiopathic sideroblastic anemias" Blood  1987
  • "Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms" American Journal of Clinical Pathology May 2011
  • "Topo IIIα and BLM act within the fanconi anemia pathway in response to DNA-crosslinking agents" Cytogenetic and Genome Research September 2009
  • "Novel inactivating mutations of FANCC in Brazilian patients with Fanconi anemia." Human Mutation February 2006
  • "Natural gene therapy in monozygotic twins with Fanconi anemia" Blood April 15 2006
  • "Embryonic lethality after combined inactivation of Fancd2 and Mlh1 in Mice" Journal of Cancer Research December 15 2009
  • "Section E9 of the American College of Medical Genetics technical standards and guidelines" Genetics in Medicine July 2011
  • "Human chromosome variation" American Journal of Human Genetics  1986
  • "Wilms tumor, AML, and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia" Pediatric Blood and Cancer March 2010
  • "Complex translocation (7;22) identified in an epithelioid hemangioendothelioma" Cancer Genetics and Cytogenetics December 1996

Additional information

Edit profile